Assessment of the Impact of the COVID-19 Pandemic on People with Rheumatic Diseases in Europe

What was the reason behind REUMAVID?

  • REUMAVID aims to assess the impact of the COVID-19 pandemic and lockdown measures on the disease activity and function, access to healthcare and treatment, support services, wellbeing, mental health, and hopes and fears of people living with rheumatic and musculoskeletal diseases (RMDs).
  • Capturing the Patients’ Perspective in order to address unmet needs on issues that matters to patients during COVID-19 pandemic and lockdown.  
  • Generating evidence-based information to raise awareness on the impact of the pandemic on patients with RMDs.
  • Providing patient organizations data that will allow to advocate for patients’ rights in crisis situations
  • Identifying the fears and hopes of patients during the pandemic

key messages

Reumavid in numbers

Patients recruited across europe
Patient Organizations
Scientific Conferences

Second REUMAVID survey

In the first survey we were able to collect valuable information on the shortcomings of healthcare and identify the main problems patients faced due to the COVID-19 pandemic.

To find out whether these problems persist or have been solved, we need to know your experience.

Your participation is important to understand the impact of the pandemic on patients with rheumatic diseases and, in this way, to establish measures to reduce the impact and improve the care and quality of life of this group.


Participating Patient Organizations


REUMAVID is a project conducted by the Health & Territory Research (HTR) group of the University of Seville (Spain)

Supported by

Privacy Policy

Terms of use

© 2021 All Rights Reserved